Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 2Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 11Head & Neck 6Thoracic 3Gynecologic 2CNS 2Other solid neoplasm 1Genitourinary 1

Conditions

Advanced and/or Metastatic Solid Tumours 1

Interventions

Cisplatin 81Gemcitabine 58Carboplatin 57Irinotecan 56Paclitaxel 53Pemetrexed 47Docetaxel 39Nivolumab 33Fluorouracil 30Bevacizumab 27pembrolizumab 25Cyclophosphamide 24Capecitabine 24Oxaliplatin 22Leucovorin 21Topotecan 19durvalumab 17Erlotinib Hydrochloride 17Sorafenib 16Everolimus 16Etoposide 16Bortezomib 16Ipilimumab 15Injections 15Sunitinib 14Filgrastim 14Early Intervention, Educational 14atezolizumab 13alvocidib 13Sirolimus 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × nimotuzumab × Other solid neoplasm × Clear all
NCT00369252 2007-02-28

Phase I Study of Nimotuzumab in Solid Tumours

YM BioSciences

Phase 1 Completed
18 enrolled
Other solid neoplasm

Advanced and/or Metastatic Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon âš¡